OpenLegislation

Division Introduction

United Kingdom

Original text. Later amendments are not shown.

  1. 1Division 1
  2. 2Division 2
  3. 3It may be necessary to conduct separate studies for metabolites, breakdown or reaction products derived from the active substance where non-target organisms may be exposed and where their effects cannot be evaluated by the available results relating to the active substance. Before such studies are performed, the applicant shall take into account the information from Sections 5, 6 and 7.
  4. 4Division 4
  5. 5Division 5
  6. 6For those guidelines which allow for the study to be designed to determine an effective concentration (ECx), the study shall be conducted to determine an EC10, EC20 and EC50, when required, along with corresponding 95 % confidence intervals. If an ECx approach is used, a no observed effect concentration (NOEC) shall still be determined.
  7. 7Division 7
  8. 8Division 8
  9. 9Division 9
  10. 10Division 10